hair growth, stop hair loss



References: Hair growth and hair loss










  • Elliptografting: the right fit.
  • IL-6 deficiency allows for enhanced therapeutic value after bone marrow transplantation across a minor histocompatibility barrier in the twitcher (globoid cell leukodystrophy) mouse.
  • A retrospective study of incontinentia pigmenti seen at the National Skin Centre, Singapore over a 10-year period.
  • research_abst
  • Efficacy and acceptability of depo-medroxyprogesterone acetate injection. As a method of contraception in Saudi Arabia.
  • The quality of life after chemotherapy in advanced non-small cell lung cancer patients
  • Xeloda (capecetabine) in the treatment of disseminated breast cancer after failure with anthracyclines and taxanes
  • Novel, dose intensive, single-agent cisplatin in the first-line management of advanced stage ovarian cancer.
  • Teloptosis, a turning point in hair shedding biorhythms.
  • Skin manifestations in patients with renal chronic renal failure on regular hemodyalysis
  • Palliative chemotherapy in non-Hodgkin's lymphoma.
  • Determination of scalp ER and AR of patients with male pattern baldness and the effects of hair transplantation on them
  • Folacin deficiency and requirement in the squirrel monkey (Saimiri sciuresus).
  • Paclitaxel and carboplatin as outpatient therapy for stage III and IV epithelial ovarian cancer.
  • Complications of heparin therapy.
  • Tinea capitis and corporis caused by Trichophyton soudanense in an immigrant family from Africa
  • Spontaneous zinc deficiency in marmosets, saguinus mystax.
  • Acanthosis nigricans: a new cutaneous sign in severe atopic dermatitis and Down syndrome.
  • research_abst
  • Mixed connective tissue disease--clinical and immunological profile.
  • Safety of titanium mesh for orbital reconstruction.
  • Ifosfamide chemotherapy ineffective for advanced pancreatic carcinoma
  • A multicenter, randomized, controlled clinical trial of interferon alfacon-1 in comparison with lymphoblastoid interferon-alpha in patients with high-titer chronic hepatitis C virus infection.
  • Atrichia with papular lesions resulting from mutations in the rhesus macaque (Macaca mulatta) hairless gene.
  • research_abst
  • The follicular automaton model: effect of stochasticity and of synchronization of hair cycles.
  • Assessment of side effects in patients with chronic hepatitis C receiving combination therapy.
  • The dosing schedule dependent toxicities of adriamycin in beagle dogs and rhesus monkeys.
  • Male pattern baldness: classification and incidence.
  • Osteopontin gene is expressed in the dermal papilla of pelage follicles in a hair-cycle-dependent manner.
  • Clinical and molecular diagnostic criteria of congenital atrichia with papular lesions.
  • 90-day oral toxicity study of a grape seed extract (IH636) in rats.
  • Ifosfamide and paclitaxel salvage chemotherapy for advanced epithelial ovarian cancer.
  • Interrelationships between athyroetic and copper-deficient states in rats.
  • Influence of vehicles on the phase transitions of model sebum.
  • Adriamycin in the treatment of childhood solid tumors. A Southwest Oncology Group study.
  • Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer -- a retrospective review of Chinese patients and comparison with an historic Western series.
  • research_abst
  • Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development.
  • Evidence for pseudodominant inheritance of atrichia with papular lesions.
  • research_abst
  • Taxotere: Clinical Trials in Non-Small Cell Lung Cancer.
  • Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer.
  • Depot medroxyprogesterone. Management of side-effects commonly associated with its contraceptive use.
  • Vogt-Koyanagi-Harada syndrome. Epidemiological, clinical and disease progression aspects. Twenty cases
  • Some concerns and semantic confusions about feminine skin
  • research_abst
  • Epidermotropic Lymphoma (Mycosis Fungoides) in an ICR Mouse.
  • Diffuse hair loss in women
  • Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hunermann syndrome.
  • research_abst
  • research_abst
  • Pulsed electrostatic fields (ETG) to reduce hair loss in women undergoing chemotherapy for breast carcinoma: a pilot study.
  • Changing patient perceptions of the side effects of cancer chemotherapy.
  • Differential T-cell reactivity to the round and oval forms of Pityrosporum in the skin of patients with psoriasis.
  • Pilotropic T-cell lymphoma without mucinosis: 5 new cases
  • Clinical evaluation of effects from neo-adjuvant chemotherapy with epirubicin plus paclitaxel in cases of locally advanced breast cancer
  • research_abst
  • Homozygosity mapping of a locus for a novel syndromic ichthyosis to chromosome 3q27-q28.
  • Myotonic dystrophy (Steinert disease): a morphologic and biochemical hair study.
  • 17alpha-estradiol induces aromatase activity in intact human anagen hair follicles ex vivo.
  • The rat shorn mutation (shn) maps between D7Got143 and D7Rat94.
  • research_abst
  • Genetic dissection of retinoic acid function in epidermis physiology
  • Desirable and undesirable cutaneous effects of oral contraceptives.
  • Protection from Radiation-Induced Alopecia with Topical Application of Nitroxides: Fractionated Studies
  • Modulation of dermal cell activity during hair growth in the rat.
  • research_abst
  • Oral contraception: failures and risks
  • Alopecia areata, autoimmunity, and Down's syndrome.
  • Oral contraceptive and dermatology.
  • Clinical use of ethinyl estradiol in combination with cyproterone acetate. Study based on 50 cases
  • Mice lacking endogenous major histocompatibility complex class II develop arthritis resembling psoriatic arthritis at an advanced age.
  • Microtubule associated protein (MAP-2) expression defines the companion layer of the anagen hair follicle and an analogous zone in the nail unit.
  • Ataxia, depression, and dermatitis associated with the use of dichlorvos-impregnated collars in the laboratory cat.
  • The gene for hypotrichosis of Marie Unna maps between D8S258 and D8S298: exclusion of the hr gene by cDNA and genomic sequencing.
  • Primary and secondary disturbances in trace element metabolism connected with genetic metabolic disorders.
  • Vitamin D3 analogs stimulate hair growth in nude mice.
  • research_abst
  • Young age at onset, renal involvement, and arterial hypertension are of adverse prognostic significance in juvenile systemic lupus erythematosus.
  • Laboratory diagnosis of the atopic condition: evaluation of a possible method based on human serum complement consumption.
  • research_abst
  • Side effects in immunosuppressive therapy
  • Selenium elimination in pigs after an outbreak of selenium toxicosis.
  • Primary follicular mucinosis: long-term follow-up of patients younger than 40 years with and without clonal T-cell receptor gene rearrangement.
  • research_abst
  • Subclinical speckled perifollicular melanosis of the scalp.
  • Lateral scalp flaps for instant results in male pattern baldness.
  • Trace element imbalance in children with environmentally induced pathology
  • Pharmacologic study of intraperitoneal paclitaxel in gastric cancer patients with peritoneal dissemination
  • Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.
  • Vitamin D and calcium dysregulation in the polycystic ovarian syndrome.
  • research_abst
  • research_abst
  • Hair transplantation in women: treating female pattern baldness and repairing distortion and scarring from prior cosmetic surgery.
  • Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer
  • research_abst
  • Neoadjuvant chemotherapy with taxotere-epirubicin-5-fluorouracil (TEF) in local-regionally advanced breast cancer: a preliminary report.
  • Sideburn reconstruction with an expanded supraauricular trapezoidal flap.
  • Satoyoshi syndrome in a Caucasian girl improved with glucocorticoids--a clinical report.
  • Corrective hair restoration techniques for the aesthetic problems of temperoparietal flaps.
  • research_abst
  • research_abst
  • Recurrent missense mutations in the hair keratin gene hHb6 in monilethrix.
  • Intravenous cyclophosphamide is the drug of choice for steroid dependent nephrotic syndrome.
  • Cutaneous T-cell lymphoma with Sezary syndrome in a dog.
  • The spectrum of cutaneous disease in multiple myeloma.
  • Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in Oman.
  • Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma.
  • research_abst
  • research_abst
  • research_abst
  • HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III.
  • A progeroid syndrome in mice is caused by defects in A-type lamins.
  • Rosacea of common male baldness.
  • Vitamin D enhances mitogenesis mediated by keratinocyte growth factor receptor in keratinocytes.
  • The magnitude of hedgehog signaling activity defines skin tumor phenotype.
  • Plasticity and cytokinetic dynamics of the hair follicle mesenchyme: implications for hair growth control.
  • Weekly paclitaxel administration in the adjuvant therapy of primary breast cancer
  • Combined chemotherapy using cisplatin, ifosfamide and bleomycin (PIB) in the treatment of advanced and recurrent cervical carcinoma.
  • BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors
  • Tension and flap advancement in the human scalp.
  • Ovarian cysts in guinea pigs: influence of age and reproductive status on prevalence and size.
  • Epirubicin, methotrexate and bleomycin (EMB) in the treatment of recurrent epidermoid cancer of the head and neck.
  • Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling.
  • Clinical study of weekly administration of paclitaxel for advanced and metastatic gastric cancer
  • Leflunomide: efficacy and safety in clinical trials for the treatment of rheumatoid arthritis.
  • Safety of Topical Minoxidil Solution: A One-Year, Prospective, Observational Study.
  • A locus for hereditary hypotrichosis localized to human chromosome 18q21.1.
  • research_abst
  • Progressive patterned scalp hypotrichosis, with wiry hair, onycholysis, and intermittently associated cleft lip and palate: clinical and genetic distinction from Marie Unna.
  • Algorithm of hair restoration surgery in children.
  • Chronic telogen effluvium.
  • Preliminary report of semimonthly 5-fluorouracil/leucovorin combined with paclitaxel in treatment of advanced gastric cancer (AGC)
  • research_abst
  • IL-35 Autoimmunity and vitiligo.
  • A rare case of autoimmune polyglandular syndrome type 3.
  • research_abst
  • The use of micrografts and minigrafts in the aesthetic reconstruction of the face and scalp.
  • The sequelae of chronic cutaneous lupus erythematosus.
  • Forum: dermopigmentation or medical tattooing. In practice ... how to perform medical tattooing?
  • Osteochondral lesions in developing rats intoxicated with thallium twenty four hours after birth.
  • A case of Mongolism in DZ female twins studied at 10 and then at 43 years of age.
  • Trombidiosis-induced dermatitis in white-tailed deer (Odocoileus virginianus).
  • Erythroderma in children: a clinico-etiological study.
  • Pharmacokinetic study and side effects of chronic daily administration of oral etoposide
  • Epirubicin as a single agent therapy for the treatment of breast cancer--a pharmacokinetic and clinical study.
  • research_abst
  • research_abst
  • Surgical treatment and long-term outcome of ferrets with bilateral adrenal tumors or adrenal hyperplasia: 56 cases (1994-1997).
  • Intravenous pulse cyclophosphamide--is it effective in children with steroid-resistant nephrotic syndrome?
  • Teniposide as single drug therapy for elderly patients affected by small cell lung cancer.
  • Is 3 alpha, 17 beta-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
  • Effects of anabolic-androgenic steroids on the pilosebaceous unit.
  • Malignant neoplasms in cyclosporin A-induced autoimmunity (CyA-AI).
  • Ultrasonic diagnosis of ovarian cysts in ten guinea pigs.
  • Treatment of mandibular squamous cell carcinoma in cats by use of mandibulectomy and radiotherapy: seven cases (1987-1989).
  • Cyclophosphamide plus vincristine and prednisone in the treatment of severe pemphigus vulgaris refractory to conventional therapy.
  • Skin changes secondary to hydroxyurea therapy.
  • Polycystic hydatid disease (Echinococcus vogeli). Treatment with albendazole.
  • Skin disorders of the laboratory woodchuck (Marmota monax): a retrospective study of 113 cases (1980-1990).
  • The predictive value of symptoms in diagnosing childhood tinea capitis.
  • The paramedian scalp reduction with posterior Z-plasty. A technique to minimize the "slot" defect.
  • A Nonredundant Human Protein Chip for Antibody Screening and Serum Profiling.
  • research_abst
  • Hairdex: a tool for evaluation of disease-specific quality of life in patients with hair diseases
  • Testosterone metabolism in human skin cells in vitro and its interaction with estradiol and dutasteride.
  • Final report on the safety assessment of triacetin.
  • Male-pattern baldness is common in men with X-linked recessive ichthyosis.
  • research_abst
  • Prediction of increased levels of androgen in women with acne vulgaris using ultrasound and clinical parameters
  • research_abst
  • Evaluation of radiation risk and work practices during cerebral interventions.
  • Overexpression of Sonic Hedgehog suppresses embryonic hair follicle morphogenesis.
  • Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
  • A founder COL17A1 splice site mutation leading to generalized atrophic benign epidermolysis bullosa in an extended inbred Palestinian family from Israel.
  • IFN-gamma-induced HLA-DR but not ICAM-1 expression on cultured dermal papilla cells is downregulated by TNF-alpha.
  • research_abst
  • Alopecia in a novel mouse model RCO3 is caused by mK6irs1 deficiency.
  • Salvage therapy for recurrent or refractory non-Hodgkin's lymphoma with etoposide, methotrexate, vindesine and prednisolone (EMVP)
  • Long-term follow-up and unusual findings after microvascular transfer of hair-bearing skin for pubic hair restoration.
  • The Rapunzel syndrome - a case report: trichobezoar as a cause of intestinal perforation
  • research_abst
  • research_abst
  • research_abst
  • Widespread livedoid vasculopathy.
  • Prevalence of skin diseases in Ibadan, Nigeria.
  • research_abst
  • Disseminated lupus vulgaris.
  • Thallium poisoning: an outbreak in Florida, 1988.
  • Olmsted syndrome with squamous cell carcinoma of extremities and adenocarcinoma of the lung: failure to detect loricrin gene mutation.
  • Non infectious skin conditions associated with diabetes mellitus: a prospective study of 308 cases
  • research_abst
  • Cutaneous manifestations of systemic lupus erythematosus in Pakistani patients.
  • The mutant gene "wal" is active in cells of mouse hair follicles
  • In Process Citation
  • research_abst
  • Diagnosis and treatment of biotinidase deficiency-clinical study of six patients
  • Cell-mediated autoimmune diseases of the skin: some hypotheses.
  • Safety and efficacy of radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin).
  • research_abst
  • Lichen planopilaris: clinical and pathologic study of forty-five patients.
  • Low-dose methotrexate treatment in noninfectious uveitis resistant to corticosteroids.
  • Sezary's syndrome
  • Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancer.
  • Alopecia areata. Autoreactive T cells are variably enriched in scalp lesions relative to peripheral blood.
  • Phase I/II study of liposome-complexed mitoxantrone in patients with advanced breast cancer.
  • Telogen effluvium due to recombinant interferon alpha-2b.
  • Assessing hair shedding in children.
  • Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: a phase II study.
  • Alopecia and dermatopathy of the lower back following pelvic fractures in three cats.
  • Selenium poisoning in fattening swine
  • Novel Hairless mutations in two kindreds with autosomal recessive papular atrichia.
  • Eosinophilia-myalgia syndrome. Natural history in a population-based cohort.
  • Intra-arterial infusion chemotherapy in the treatment of advanced breast cancer--doxorubicin versus epirubicin
  • research_abst
  • Time-dose relationship of erythema in high energy photon irradiation therapy
  • Two different mutations in the same codon of a type II hair keratin (hHb6) in patients with monilethrix.
  • Epidemiological, clinical, haematological and biochemical characteristics of canine hypothyroidism.
  • A model of left ventricular dysfunction caused by intracoronary adriamycin.
  • IL-7 overexpression in transgenic mouse keratinocytes causes a lymphoproliferative skin disease dominated by intermediate TCR cells: evidence for a hierarchy in IL-7 responsiveness among cutaneous T cells.
  • Interleukin-1beta-induced inhibition of hair growth in vitro is mediated by cyclic AMP.
  • Toxicity and side-effects of combination chemohormonal therapy of advanced breast cancer.
  • Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice.
  • Combination of 5-fluorouracil, imidazole carboxamide, BCNU and prednisolone (FIB-P) as a salvage chemotherapy in heavily pretreated breast cancer patients.
  • Antineoplastic effectiveness and unwanted side effects of polychemotherapy of extensive oro- and hypopharyngeal cancers--results of a prospective therapy study with 5-FU/cisplatin versus 5-FU/carboplatin
  • Lymphocytic/plasmacytic gastroenteritis in cats: 14 cases (1985-1990).
  • A clinical trial of the oral form of 4'-demethyl-epipodophyllotoxin-beta-D ethylidene glucoside (NSC 141540) VP 16-213.
  • Intrapleural administration of pirarubicin in the treatment of malignant pleural effusion
  • Cisplatin and teniposide chemotherapy for advanced non-small cell lung cancer.
  • Study of the zinc content of hair and serum in selected skin diseases
  • research_abst
  • The density issue in hair transplantation.
  • Palliative radio-chemotherapy with ifosfamide and BCNU for breast cancer patients with cerebral metastases. A 5-year experience.
  • Doxorubicin and cyclophosphamide, alternated with bleomycin and mitomycin C as a second-line regimen in advanced ovarian carcinoma resistant to cisplatin-based chemotherapy.
  • The COP-BLAM therapy for malignant lymphoma
  • Effect of dietary tin deficiency on growth and mineral status in rats.
  • High pedicle scalp flaps
  • Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.
  • Pharmacologic effects of biotin on epidermal cells
  • A clinical and pharmacological study of high-dose mitozolomide given in conjunction with autologous bone marrow rescue.
  • Interleukin 1 protects hair follicles from cytarabine (ARA-C)-induced toxicity in vivo and in vitro.
  • Micrografts and minigrafts: a new approach for baldness surgery.
  • A comparison of the scalp kinetics in scalp-lifting with and without an intact occipital neurovascular bundle.
  • Notoedric acariasis in the porcupine (Erethizon dorsatum).
  • On the localization of effector cells in cyclosporin-induced autoimmunity.
  • Studies on the inheritance of hair loss in the Irish water spaniel.
  • Pachyonychia congenita-like disorder in cotton-top tamarins (Saguinus oedipus oedipus).
  • Hair growth on nude mice due to cyclosporin A.
  • PUVA treatment in Sweden.
  • Hormonal parameters in androgenetic hair loss in the male.
  • MMAF for advanced gastric cancer.
  • Use of tissue expanders on the scalp
  • An early phase II study of CPT-11 in primary lung cancer
  • The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer.
  • Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial.
  • The loss of contact sensitization in man.
  • Fibromyalgia in lupus erythematosus.
  • 5-Fluorouracil, epirubicin and cyclophosphamide (FEC combination) in advanced breast cancer.
  • Adjuncts to scalp reduction surgery. Intraoperative tissue expanders and hyaluronidase.
  • A new scalp flap for baldness.
  • Chemotherapy with high dose ifosfamide/mesna plus cisplatin for the treatment of ovarian cancer: a study of the Grupo de Estudio y Tratamiento Latino-Americano del Cancer.
  • Measurement of human hair growth by optical microscopy and image analysis.
  • Alopecia areata in children: response to treatment with diphencyprone.
  • Hair loss in children and adolescents.
  • Clinical aspects and surgical treatment of hyperadrenocorticism in the domestic ferret: 94 cases (1994-1996).
  • Perceptions of problematic events and quality of care among patients and parents after successful therapy of the child's malignant disease.
  • Natural progression of male pattern baldness in young men.
  • Cutaneous manifestations in trisomy 21
  • A special tissue expander in combination with extensive scalp-lifting.
  • Permanent hair loss after Kerion Celsi
  • High-dose epirubicin for untreated patients with advanced tumours: a phase I study.
  • Treatment of small cell anaplastic carcinoma of the lung with the oral solution of VP-16-213 (NSC 141540, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside).
  • Cryosectioning of hair follicles. An improved method using liquid nitrogen conduction freezing.
  • Applications and complications of tissue expansion in pediatric patients.
  • Hormones and hair growth in man
  • Chemotherapeutic combinations of mutually potentializing drugs. 1-Application to the treatment of breast cancers
  • Hairline design and placement.
  • research_abst
  • Weekly dose adriamycin as first line chemotherapy in advanced breast cancer.
  • CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity.
  • research_abst
  • The effects of topical diazoxide on hair follicular growth and physiology of the stumptailed macaque.
  • Regional scalp differences of the androgenic metabolic pattern in subjects affected by male pattern baldness.
  • Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer.
  • Phase I evaluation of thio-TEPA in combination with cisplatin for advanced gynecologic malignancies.
  • Practical treatments of suppurative skin mycoses and allergic skin mycoses due to Candida
  • Safety surveillance of esterified estrogens-methyltestosterone (Estratest and Estratest HS) replacement therapy in the United States.
  • Erythema multiforme-like eruptions: a rare side effect of topical immunotherapy with diphenylcyclopropenone.
  • A study of combined chemotherapy with MMC, ADM, CDDP, etoposide (VP-16), 5'DFUR (MAC-VD therapy) in advanced cancer and local relapse of the stomach
  • Phase I study of oral menogaril administered on a once weekly schedule.
  • Different strains of donor parental lymphoid cells induce different models of chronic graft-versus-host disease in murine (Balb/c x A/J)F1 hybrid hosts.
  • Pirarubicin in advanced breast cancer: a French cooperative phase II study.
  • Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors.
  • Single-agent oral etoposide for elderly small cell lung cancer patients.
  • Phase II trial of cytarabine, cisplatin and vindesine for advanced non-small cell lung cancer.
  • Phase II study of 4-demethoxydaunorubicin in previously untreated extensive disease non-small cell lung cancer.
  • Hormonal abnormalities in Pomeranians with normal coat and in Pomeranians with growth hormone-responsive dermatosis.
  • Chemotherapeutic combinations of mutually potentiating drugs. 2-Application to the treatment of bronchial cancers
  • Outcome of scalp donor sites in 450 consecutive pediatric burn patients.
  • Effect of Fluosol-DA 20% and oxygen on response of C57BL/6 mice to whole-body irradiation.
  • Phase II study of oral idarubicin in elderly patients with advanced breast cancer.
  • Sequestrated meningoceles of scalp: extracranial meningeal heterotopia.
  • Digital imaging techniques in dermatology.
  • NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease.
  • Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: a spectrum of sclerodermatous skin disease.
  • cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung.
  • Psychological problems with hair loss in general practice and the treatment policies of general practitioners.
  • Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas.
  • Analysis of apoptosis during hair follicle regression (catagen)
  • Combination chemotherapy with pirarubicin (THP), cyclophosphamide, vincristine, and prednisolone (VEP-THP therapy) in the treatment of non-Hodgkin's lymphoma.
  • Phase I clinical study of MX2 (KRN 8602)
  • Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance.
  • Phase II study of pirarubicin (THP-adriamycin) in metastatic breast cancer patients.
  • Tufted folliculitis. A specific bacterial disease?
  • Phase II clinical trial of VP-16-213 (etoposide) administered orally in advanced ovarian cancer.
  • The effect of a supplement of citric acid on the bioavailability of zinc from corn germ
  • The scalp as a donor site: revisited.
  • Teniposide in recurrent or advanced cervical carcinoma: a phase II trial in patients not previously treated with cytotoxic therapy.
  • Treatment of metastatic breast cancer with the combination of ifosfamide, epirubicin and 5-fluorouracil.
  • Clinical features of systemic lupus erythematosus in Sri Lankan patients: results from a lupus clinic.
  • A phase II study of intensive-dose epirubicin/verapamil as induction therapy followed by intensive-dose ifosfamide for advanced breast cancer.
  • Biotinidase deficiency--a progressive metabolic disease in children with seizures and ataxia
  • Trichotillomania: a histopathologic study in sixty-six patients.
  • 4'-O-tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study.
  • A retrospective study of 200 cases of lichen
  • Pirarubicin (4'-o-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer. A Clinical Phase II study.
  • Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen.
  • Alopecia areata and universalis in the Smyth chicken model for spontaneous autoimmune vitiligo.
  • The clinico-dermatological and morphological characteristics of the hair involvement in children with chemical poisoning
  • Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
  • Biphasic effects of minoxidil on the proliferation and differentiation of normal human keratinocytes.
  • A combination of cyclophosphamide, methotrexate, vincristine and VP 16-213 (NSC 141 540) in the treatment of bronchogenic carcinoma.
  • Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
  • Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancer.
  • Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary.
  • Combination of 4-epi-doxorubicin and irradiation--a new approach in the treatment of locoregionally advanced inoperable esophageal cancer.
  • Comparison of 32P therapy and sequential hemibody irradiation (HBI) for bony metastases as methods of whole body irradiation.
  • Potentiation by Rabdosia rubescens on chemotherapy of advanced esophageal carcinoma
  • research_abst
  • Phase II study of peplomycin in breast cancer. A cooperative study. Clinical Study Group of Peplomycin for Breast Cancer in Japan
  • Hair root studies in patients suffering from primary and secondary syphilis.
  • Toxicity of FED chemotherapy in non-small-cell lung cancer.
  • Social situation of persons with dermatoses as a phenomena of interpersonal perception
  • Cutaneous lesions in capsaicin-pretreated rats. A trophic role of capsaicin-sensitive afferents?
  • New combination of epirubicine, bleomycin, vinblastine and prednisone (EBVP II) before radiotherapy in localized stages of Hodgkin's disease. Phase II trial in 50 patients
  • Treatment of advanced head and neck tumors with PEV-B regimen: a pilot study.
  • Tonsure reduction. Principles and innovation: scalp lift
  • Studies on the effect of bleomycin on hair growth dynamics in rats
  • Effects of the deregulated expression of human interleukin-2 in transgenic mice.
  • Albendazole in the treatment of hepatic and intra-abdominal hydatidosis
  • Phase I clinical and pharmacokinetic study of thiotepa administered intraperitoneally in patients with advanced malignancies.
  • Vincristine, adriamycin, mitomycin-C and UFT (VAM-UFT) therapy in progressive or recurrent breast cancer
  • Effect of combination of 5-fluorouracil, epirubicin and mitomycin C (FEM) on advanced gastric carcinoma.
  • Efficacy of combination chemotherapy with mitoxantrone, vincristine, doxifluridine and prednisolone for recurrence of breast cancer
  • The prevalence of skin manifestations in thyrotoxicosis--a retrospective study.
  • Neuroectodermal dysplasia in 2 Uzbek families
  • Thirteen-weeks subcutaneous treatment with high dose of natural sex hormones in rats with special reference to their effect on the pituitary-gonadal axis. I. Oestradiol.
  • Phase II study of mitoxantrone in unresectable primary hepatocellular carcinoma following hepatitis B infection.
  • Ifosfamide, mitomycin and radiotherapy in non-small-cell lung cancer.
  • VP16, epirubicin and procarbazine in the treatment of advanced non-small-cell lung cancer.
  • The role of prophylactic cranial irradiation in regionally advanced non-small cell lung cancer. A Southwest Oncology Group Study.
  • Phase I and pharmacodynamic study of taxol in refractory acute leukemias.
  • Preliminary approach to the mental component in dermatologic patients
  • Mucocutaneous complications of intraarterial 5-bromodeoxyuridine and radiation.
  • Subcutaneous low doses of interleukin-2 and recombinant interferon alpha with carboplatin and vinblastine in patients with advanced melanoma.
  • Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer
  • Cyclophosphamide, tetrahydropyranyl-adriamycin, and cis-platinum in the treatment of head and neck adenocarcinoma.
  • Clinico-laboratory parallels in changes in the cerebrospinal fluid and the immune status of patients with early stages of syphilis
  • Alopecia areata: appropriateness of various laboratory parameters
  • Mitoxantrone, methotrexate, and 5-fluorouracil (MMF) in hormone-refractory advanced breast cancer.
  • The Brocq pseudopelade--a disease picture or disease entity
  • Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients.
  • Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. The Clinical Screening Group of the European Organization for Research and Treatment of Cancer.
  • Phase I clinical trial and pharmacokinetic evaluation of 4'-0-tetrahydropyranyladriamycin (THP-adriamycin).
  • Effect of Dermacentor albipictus (Acari:Ixodidae) on blood composition, weight gain and hair coat of moose, Alces alces.
  • Effects of liposteroid on skin lesions in autoimmune MRLlpr/lpr mice.
  • Experience with intermediate-dose (110-120 mg/m2) epirubicin.
  • Experience with combinations containing mitoxantrone in the treatment of adult acute leukemias.
  • A six-month chronic dietary toxicity study of pyriproxyfen in rats
  • Efficacy of ivermectin against mange and gastrointestinal nematodes of buffalo (Bubalus bubalis).
  • Phase II study with etoposide in previously untreated advanced breast cancer.
  • Clinico-biochemical parallels in patients with early forms of syphilis and pathology of the cerebrospinal fluid
  • Intra-arterial infusion chemotherapy of advanced breast cancer--effects and side effects of adriamycin, 4'-epi-adriamycin and THP-adriamycin
  • Elliptinium: phase II study in advanced measurable breast cancer.
  • Chronic cyclosporine-induced autoimmune disease in the rat: a new experimental model for scleroderma.
  • Induction chemotherapy with cisplatin and continuous infusion 5-fluorouracil in locally far-advanced head and neck cancer.
  • Transient virus infection and pathogenesis of a new HIV type 2 isolate, UC12, in baboons.
  • Can androgen deficiency promote an outbreak of psoroptic mange mites in male deer?
  • Suppressive effect of zinc ion on iNOS expression induced by interferon-gamma or tumor necrosis factor-alpha in murine keratinocytes.
  • Phase II study of oral VP-16-213 in small cell lung cancer.
  • A genetic, pathological and virological study of congenital hypotrichosis and incisor anodontia in cattle.
  • The efficacy of high-dose 4'epidoxorubicin in hepatocellular carcinoma.
  • Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancer.
  • Phase I study of taxol using a 5-day intermittent schedule.
  • Phase I clinical and pharmacokinetic study of taxol.
  • The pharmacokinetics and toxicity of the anthrapyrazole anti-cancer drug CI-941 in the mouse: a guide for rational dose escalation in patients.
  • Enhanced cutaneous radiation effects following high-dose busulfan therapy.
  • Nomenclature proposal for the zones and landmarks of the balding scalp.
  • Analysis of the DS86 atomic bomb radiation dosimetry methods using data on severe epilation.
  • Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease.
  • Chronic daily administration of oral etoposide--a phase I trial.
  • Food hypersensitivity in cats: 14 cases (1982-1987)
  • Follicular mucinosis. A reaction pattern in follicular epithelium.
  • VEDex (vincristine, epirubicin dexamethasone): an effective and well tolerated palliative chemotherapy regimen for non-Hodgkin's lymphoma.
  • Phase I study of intravenous menogaril administered intermittently.
  • Value of laboratory parameters in androgenization in the female with special reference to the "free androgen index"
  • Serum elevation of dehydroepiandrosterone sulfate associated with male pattern baldness in young men.
  • Clinical implications of immunologic phenotyping in cutaneous T cell lymphoma.
  • Effect of very high single dose of cisplatinum and of radiation on the brain of the rabbit.
  • Phase II trial of menogarol in the treatment of advanced adenocarcinoma of the pancreas.
  • Efficiency of acitretin in the treatment of cutaneous lupus erythematosus.
  • Physiopathological approach to seborrhea of the scalp
  • Complement-fixing gastric parietal cell autoantibodies. A good marker for the identification of type A chronic atrophic gastritis.
  • Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
  • research_abst
  • Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.
  • A phase I study of intravenous iododeoxyuridine as a clinical radiosensitizer.
  • A phase II study of etoposide (NK 171) in small cell lung cancer--comparison of results between intravenous administration and oral administration
  • Alopecia in mice infected with murine cytomegalovirus (MCMV).
  • Clinical characteristics of primary hypothyroidism in Dakar. Apropos of 37 cases
  • Small cell lung cancer: results of a phase II study of 1,2,4 triglycidylurazol.
  • A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas.
  • A phase II study of epirubicin in advanced lung cancer
  • Combination chemotherapy with CDDP and 5-FU in head and neck cancer.
  • Hepatic arterial infusion of mitoxantrone in the treatment of primary hepatocellular carcinoma.
  • A phase II study of vindesine for pretreated non-small cell lung cancer
  • Diffuse well-differentiated lymphocytic lymphoma: chemotherapy with BCNU, cyclophosphamide, vincristine, melphalan and prednisone.
  • Sequential high-dose cytarabine therapy in combination with asparaginase in acute myeloid leukemia
  • Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease.
  • A phase II clinical trial of the combination mitomycin C, adriamycin, and cis-diamminedichloroplatinum in patients with advanced upper aerodigestive cancer.
  • Use of the scalp as a donor site for large burn wound coverage: review of 150 patients.
  • Ifosfamide in advanced pancreatic cancer. A 5-year experience.
  • Long-term treatment with sodium valproate: monitoring of venous ammonia concentrations and adverse effects.
  • 5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)".
  • Phase I clinical trial and pharmacokinetics of weekly ICRF-187 (NSC 169780) infusion in patients with solid tumors.
  • Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group.
  • Wigs as medical aids. Selection, care and cost regulation
  • Phase II study of combination chemotherapy with epirubicin, cyclophosphamide and ftorafur in metastatic breast cancer
  • Chronic graft-versus-host disease in rats after syngeneic bone marrow transplantation.
  • Phase II trial of idarubicin in patients with advanced lymphoma.
  • Combination chemotherapy with 5-fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer--an open phase II study.
  • Paclitaxel plus vinorelbine in metastatic breast Ca patients with contraindications to receive anthracyclines.
  • Gemcitabine: safety profile unaffected by starting dose.
  • Phase I-II study of epirubicin in multiple myeloma.
  • Reversal of Hair Loss following Vertical Gastroplasty when Treated with Zinc Sulphate.
  • Complications of controlled tissue expansion in the pediatric burn patient.
  • Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation.
  • Phase I--preliminary phase II trial of iproplatin, a cisplatin analogue.
  • Urologic syndrome associated with wire caging in AKR mice.
  • Cyclophosphamide, adriamycin, DTIC and vincristine with methotrexate in the treatment of advanced soft tissue sarcomas.
  • Psychological implications of cancer. II. Consequences of treatment and modality of adaptation
  • Etoposide and cisplatin in advanced esophageal cancer. A preliminary report.
  • research_abst
  • Alopecia areata and cytomegalovirus infection in twins: genes versus environment?
  • Dinitrochlorobenzene is inherently mutagenic in the presence of trace mutagenic contaminants.
  • A new classification of male pattern baldness and a clinical study of the anterior hairline.
  • Methodology of validation of criteria for SLE.
  • Side-effects of spironolactone therapy in the hirsute woman.
  • Tissue expansion and flaps for surgical correction of male pattern baldness.
  • Percutaneous penetration of squaric acid and its esters in hairless mouse and human skin in vitro.
  • Practical small animal dermatology. II: Diagnostic approach.
  • The one-stage preauricular flap for male pattern baldness: long-term results and risk factors.
  • Useful cutaneous markers of internal malignancy in the early stage
  • Effect of intra-arterial infusion of adriamycin on locally advanced primary breast cancer--third report. Clinical Study Group of Adriamycin for Breast Cancer in Japan
  • Undermining of the scalp: quantitative effects.
  • research_abst
  • Reduced disease in aged rats treated chronically with ibopamine, a catecholaminergic drug.
  • Arterial regional chemotherapy of advanced breast cancer
  • A phase I and pharmacokinetic study of amphethinile.
  • Adriamycin, vincristine and mitomycin C as first and second line therapy for advanced breast carcinoma.
  • Dysthymic states and depressive syndromes in physical conditions of presumably psychogenic origin.
  • Treatment of male baldness exclusively with mini-grafts
  • One-year chronic dietary toxicity study of d.d-T80-prallethrin in rats
  • Phase I study of oral idarubicin given with a weekly schedule.
  • Phase II study of epirubicin on breast cancer: a cooperative group study
  • Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year.
  • Oral idarubicin in combination with cytosine-arabinoside in previously untreated patients with acute non-lymphocytic leukemia.
  • Effectiveness and toxicity of high-dosage Ara-C. Clinical observations in 10 cases and review of the literature
  • Phase II study of etoposide (VP-16) in the form of intravenous injection for malignant lymphomas and acute leukemias: Hanshin Cooperative Study Group for Hematological Disorders
  • A phase II study of epirubicin in acute leukemia: a cooperative group study.
  • A phase I trial of idarubicin by oral administration
  • Phase I-II trial of high-dose epirubicin in patients with lymphoma.
  • Phase II study of aclarubicin in acute myeloblastic leukemia.
  • Antibodies to phospholipids and nuclear antigens in patients with repeated abortions.
  • Antiphospholipid antibodies in a series of 25 cases of lupus without antinuclear antibodies. Comparison with a series of 91 lupus patients with antinuclear antibodies
  • Neurotropic response of Spiroplasma mirum following peripheral inoculation in the rat.
  • Relationship between the experience of steroids side effects and noncompliance with oral steroids treatment in collagen disease patients
  • Clinical, clinicopathologic, and epidemiologic features of anhidrosis in central Florida Thoroughbred horses.
  • Forkhead/winged-helix transcription factor Whn regulates hair keratin gene expression: molecular analysis of the nude skin phenotype.
  • Computer-aided quantification of scalp hair.
  • Action of topical minoxidil in the bald stump-tailed macaque.
  • Thyroid autoantibodies: a good marker for the study of symptomless autoimmune thyroiditis.
  • Dermatologic complications of oral hormonal contraception (Gravistat)
  • An oriented phase II trial of THP-adriamycin in breast carcinoma.
  • Ornithine decarboxylase transgenic mice as a model for human atrichia with papular lesions.
  • Advancement in scalp grafts.
  • The effect of corticosteroids on postoperative edema.
  • Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells.
  • New combination chemotherapy against drug-resistant choriocarcinoma
  • A 13-week vapor inhalation study of 3,3-dimethyl-2-butanol in Sprague-Dawley rats.
  • Diagnosis and management of the hair loss patient.
  • Simultaneous radiotherapy and chemotherapy in the treatment of brain metastases of malignant solid tumours.
  • Alopecia areata in children
  • Phase I clinical investigation of benzisoquinolinedione.
  • Factors influencing the response of normal tissue to radiation
  • Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
  • Toxicological studies on (2''R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic. Acute toxicity study in mice
  • High-dose teniposide for refractory malignancies: a phase I study.
  • Coat color in dogs. 2: Clinical significance
  • Alopecia induced in young mice by exposure to excess dietary zinc.
  • First-line mitoxantrone chemotherapy for advanced breast cancer.
  • Phase II study of 4'-deoxydoxorubicin in advanced colorectal cancer.
  • Quantification of scalp hair--a computer-aided methodology.
  • Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group
  • Phase I study of alpha 2-interferon plus doxorubicin in patients with solid tumors.
  • Effects of etoposide in testicular tumors
  • Scalp expansion flaps.
  • Toxicity, ultrastructural effects, and metabolic studies with 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane(o,p'-DDD) and its methyl analog in the guinea pig and rat.
  • Topical minoxidil. A survey of use and complications.
  • Effect of retinoid analogues on mammary cancer in transgenic mice with c-neu breast cancer oncogene.
  • Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancer.
  • A clinical and pharmacokinetic phase I study of 1,2,4-triglycidylurazol (TGU, NSC 332488).
  • Ectoparasitic infestation of dogs in Bendel State, Nigeria.
  • Cisplatin, adriamycin and cyclophosphamide (PACe) combination chemotherapy in patients with ovarian carcinoma resistant to chlorambucil.
  • Phase I-II evaluation of carminomycin in adults with acute leukemia.
  • Trichological examinations in women suffering from diabetes mellitus
  • Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancer.
  • Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.
  • The human hair follicle immune system: cellular composition and immune privilege.
  • Tinea capitis in Benghazi, Libya.
  • Diffuse hair loss in women: the psychopathology of those who complain.
  • Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma.
  • Hair transplantation, scalp reduction, and flap rotation in black men.
  • A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration
  • The correction of scalp hair defects by tissue expansion.
  • Alopecia areata: alterations in the hair growth cycle and correlation with the follicular pathology.
  • Total IgE levels in the serum in dermatologic diseases
  • Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study
  • Therapeutic effect of sequential doses of methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced gastric cancer: comparison of intermediate-dose MTX with high-dose MTX
  • Is cancer treatment toxicity accurately reported?
  • Pathogenicity of aeromonas.
  • Rapid Fire Hair Implanter Carousel. A new surgical instrument for the automation of hair transplantation.
  • Hairline aesthetics and styling in hair replacement surgery.
  • Hormones and hair patterning in men: a role for insulin-like growth factor 1?
  • Failure of scalp hypothermia to prevent hair loss when cyclophosphamide is added to doxorubicin and vincristine.
  • Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study.
  • Mitoxantrone in refractory acute leukemia in children: a phase I study.
  • Hepato- and neuro-toxicity by ethylenthiourea.
  • Polychemotherapy with carmustine, cyclophosphamide plus adriamycin in the treatment of advanced ovarian cancer.
  • Cisplatin, etoposide, and radiotherapy in regional inoperable squamous cell carcinoma of the bronchus.
  • Cis-dichlorodiammineplatinum (cis-platinum) and etoposide (VP-16) in malignant lymphoma--an effective salvage regimen.
  • cis-Platinum and vindesine in combination in the treatment of non-small cell lung cancer.
  • Cyclophosphamide, adriamycin, 5-fluorouracil and high-dose toremifene for patients with advanced/recurrent breast cancer. The Japan Toremifene Cooperative Study Group.
  • Oral single-dose toxicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo
  • A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population.
  • Phase II study of etoposide (VP-16) in the treatment of advanced head and neck cancer.
  • Frontal subcutaneous blood flow, and epi- and subcutaneous temperatures during scalp cooling in normal man.
  • Trauma, sports, and the skin.
  • Mitoxantrone in a combination regimen in advanced breast cancer
  • Zinc deficiency in pregnant rhesus monkeys: effects on behavior of infants.
  • The esthetics of hair transplantation.
  • Steroid 5alpha-reductase inhibitory activity and hair regrowth effects of an extract from Boehmeria nipononivea.
  • Reconstruction of scalp defects using simple designed bilobed flap.
  • Galvanized caging as a potential factor in the development of the "fading infant" or "white monkey" syndrome.
  • Confirmation of linkage of Clouston syndrome (hidrotic ectodermal dysplasia) to 13q11-q12.1 with evidence for multiple independent mutations.
  • Personal experiences with Minitrol
  • Prevalence of cutaneous manifestations in 200 patients with eating disorders.
  • Canine hyperadrenocorticism: pretreatment clinical and laboratory evaluation of 117 cases.
  • Combined immunodeficiency and reticuloendotheliosis with eosinophilia.
  • Phase II study of adriamycin, 5-fluorouracil, levamisole, and irradiation in carcinoma of the bladder.
  • Early clinical trial with quelamycin.
  • Vindesine. A clinical trial with special reference to neurological side effects.
  • Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention
  • Hair loss and contraceptives.
  • Innovative adjuncts in hair transplantation.
  • Tufted folliculitis of the scalp: a distinctive clinicohistological variant of folliculitis decalvans.
  • Hereditary mucoepithelial dysplasia: a disease apparently of desmosome and gap junction formation.
  • Neonatal and infantile erythrodermas: a retrospective study of 51 patients.
  • Modeling the dynamics of human hair cycles by a follicular automaton.
  • Three variations of hairlessness associated with albinism in the laboratory rat.
  • Initial clinical studies with bruceantin.
  • Paclitaxel (Tesu) as a single agent in the treatment of breast cancer
  • Effects observed during subchronic administration of l-alpha-acetylmethadol (LAAM) to guinea pigs.
  • The state of the art. Donor site harvest, graft yield estimation, and recipient site preparation for follicular-unit hair transplantation.
  • Evaluation of past and present hair replacement techniques. Aesthetic improvement, effectiveness, postoperative pain, and complications.
  • Subacute toxicological evaluation of sclerotia of Sclerotinia sclerotiorum in rats.
  • Current distribution of sarcoptic mange in wombats.
  • Doxorubicin/B.C.N.U. chemotherapy for multiple myeloma in relapse.
  • Protein synthesis in zinc deficient rats during tularemia.
  • Non-anastomotic bypass surgery for childhood moyamoya disease using dural pedicle insertion over the brain surface combined with encephalogaleomyosynangiosis.
  • Alopecia induced by inhalation exposure to phenyl glycidyl ether.
  • Chemotherapy of the non-small cell carcinoma of the lung with ifosfamide and cisplatin
  • Use of oral VP16-213 as primary chemotherapeutic agent in treatment of gestational trophoblastic disease.
  • The use of the vacuum extractor in a Nigerian hospital.
  • Combined modalities in the management of advanced head and neck cancers.
  • Alopecia in thyroid diseases: characteristic trichograms
  • Further experience in treating patients with hepatocellular carcinoma in Uganda.
  • Stressful life events and loss of hair among adult women, a case-control study.
  • Combination chemoimmunotherapy for advanced renal carcinoma with Adriamycin, bleomycin, vincristine, cyclophosphamide, plus BCG.
  • Immunofluorescence studies on C1Q in mast cells.
  • Identification of mononuclear cells in cell suspension from cutaneous infiltrates freed by a suction blister method.
  • The effect of L-3, 4-dehydroproline on the antitumor activity and toxicity of bleomycin.
  • Japanese-French cooperation in tumor pharmacotherapy: 1970-1990
  • Combination chemotherapy (BEAM regimen) for head and neck cancer
  • Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
  • Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).
  • Clinical aspects and therapy of anaplastic T-zone lymphoma
  • CDDP-containing combination chemotherapy for advanced lung cancer
  • Permanent hair removal by normal-mode ruby laser.
  • The effect of the antiandrogen II alpha-hydroxyprogesterone on sebum production and cholesterol concentration of sebum.
  • Concurrent chemotherapy and radiotherapy in invasive cervical cancer patients with high risk factors.
  • Pharmacological basis for clinical use of antiandrogens.
  • Hair transplantation using local hypothermia.
  • research_abst
  • Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemio.
  • Effects of antiandrogen treatment on the sexuality of women with hyperandrogenism.
  • Therapy of severe acne and acne rosacea with oral 13-cis-retinoic acid (Isotretinoin)
  • What should be known of the Vogt-Koyanagi-Harada disease?
  • Dermatological complications in immunosuppressed patients after kidney transplantation
  • Update on laser-assisted hair transplantation.
  • Phase I trial of combination therapy with PALA and 5-FU.
  • Treatment of small cell lung cancer with a combination of VP16-213 and cyclophosphamide with cisplatin or radiotherapy.
  • Variety of determinants in an adrenal antigen common to man and some animals.
  • Alternating multiagent chemotherapy for advanced ovarian cancer.
  • Chemotherapy of hepatocellular carcinoma--with special reference to one-shot intra-arterial infusion of a high dose of adriamycin
  • Chemotherapy of refractory germ cell cancer with Etoposide.
  • Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
  • Oral toxicity of ferric dimethyl-dithiocarbamate (ferbam) and tetramethylthiuram disulfide (thiram) in rodents.
  • Ambulatory chemotherapy of hematosarcoma
  • research_abst
  • Desmoglein 3 anchors telogen hair in the follicle.
  • Efficacy and safety of leflunomide in active rheumatoid arthritis.
  • The epizootiology and pathology of sarcoptic mange in coyotes, Canis latrans, from south Texas.
  • 10 years' use of ftorafur in tumor chemotherapy at the Robert Rossle Institute. A retrospective analysis from the clinical-toxologic point of view
  • Treatment of refractory acute leukemia with aclacinomycin-A.
  • Non allergic skin reactions of drugs
  • Staging laparotomy in cutaneous T-cell disease.
  • Survey of thyroglobulin autoantibodies in dogs.
  • Phase I clinical investigation of homoharringtonine.
  • Bisantrene (NSC 337766) (CL 216,942) in advanced breast cancer. A cancer and leukemia group B study.
  • An analysis of various aspects of atomic bomb dose estimation at RERF using data on acute radiation symptoms.
  • research_abst
  • Characterization of a new antigen-antibody system (Su) in patients with systemic lupus erythematosus.
  • Phase I study of 7-N-(p-hydroxyphenyl)-mitomycin C.
  • Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma.
  • The Kockum study: twenty-two-year follow-up. Coronary heart disease in a population in the south of Sweden.
  • Ro 15-1570, a new sulfur-containing retinoid devoid of bone toxicity in rats.
  • Mitoxantrone in advanced breast cancer--a phase II study with special attention to cardiotoxicity.
  • An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
  • Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
  • Induction polychemotherapy of non-Hodgkin's lymphomas in children
  • Evaluation of the LSA2L2 protocol for treatment of childhood non-Hodgkin's lymphoma. A report from the Polish Children's Leukemia/Lymphoma Study Group.
  • Tissue expander complications in the pediatric burn patient.
  • Phase II evaluation of aclacinomycin A (ACM-A, NSC208734) in patients with metastatic colorectal cancer.
  • Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer.
  • A phase II study of 4'-epi-doxorubicin plus cis-platinum in advanced solid tumors.
  • A phase-II clinical trial of 4'-epi-doxorubicin in advanced solid tumors.
  • m-AMSA: phase II trial in advanced lymphoma and leukemia.
  • Clinical evaluation of 4'-epi-doxorubicin in advanced solid tumors.
  • A phase I study of 4'-epi-adriamycin, a new anthracycline anticancer agent
  • VP 16-213 and cytosine-arabinoside combination chemotherapy for refractory acute lymphoblastic leukemia in adults.
  • Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
  • Evaluation of multidisciplinary treatment of bladder cancer, especially in chemoimmunotherapy (ADM and OK-432) as a consolidation therapy.
  • Comparative grepafloxacin phototoxicity in mouse skin.
  • Electron microscopic study of experimental thallotoxicosis.
  • Combination chemotherapy for metastatic breast cancer with fluorouracil, adriamycin, cyclophosphamide, and methotrexate.
  • Intermediate dose single agent cyclophosphamide chemotherapy of advanced breast cancer.
  • Murine graft-versus-host skin disease: a chronologic and quantitative analysis of two histologic patterns.
  • Phase I study of an oral administration of VP 16-213
  • Chemotherapy of metastasizing breast cancer. Adriamycin mono and combination therapy after LMFP pretreatment
  • Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling.
  • Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancer.
  • Weekly doxorubicin in endocrine-refractory carcinoma of the prostate.
  • Phase I trial with 4'-deoxydoxorubicin (esorubicin).
  • Phase II trial of diaziquone (AZQ) in advanced malignant melanoma.
  • Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma.
  • Moderate-dose cyclophosphamide for disseminated ovarian carcinoma: a phase II study.
  • Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of advanced nonsquamous cell head and neck cancer.
  • Efficacy of ivermectin against Onchocerca cervicalis microfilarial dermatitis in horses.
  • Constant intraperitoneal 5-fluorouracil infusion through a totally implanted system.
  • High-dose cyclophosphamide. An effective treatment for advanced refractory multiple myeloma.
  • "Stretch-back" in scalp reductions for male pattern baldness.
  • Association of parvoviruses with rheumatoid arthritis of humans.
  • Nature of the black zones in hair following ingestion of thallium
  • Skin changes after forty.
  • Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer.
  • Small mammal populations and community under conditions of extremely high thallium contamination in the environment.
  • Zinc deficiency in rhesus and bonnet monkeys, including effects on reproduction.
  • research_abst
  • Phase I trial of pentamethylmelamine in patients with previously treated malignancies.
  • Phase I trial of ICRF-187 by 48-hour continuous infusion.
  • Androgenetic amenorrhea
  • Psychosomatic concepts in dermatology. A dermatologist-psychoanalyst's viewpoint.
  • Co-administration of adriamycin and 5-fluorouracil for the treatment of advanced stomach cancer
  • Nasal dermatitis in the Mongolian gerbil.
  • Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate.
  • Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency.
  • Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse.
  • Effect of thyroid hormone supplementation on chronic doxorubicin (adriamycin)-induced cardiotoxicity and serum concentrations of T3 and T4 in dogs.
  • Chemotherapy of metastatic urothelial carcinoma
  • Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine.
  • Combination chemotherapy of primary gastric lymphoma with vincristine, endoxan (cyclophosphamide), prednisolone and adriamycine (VEPA)
  • Clinical phase I study of aclacinomycin A by evaluation of an intermittent intravenous administration schedule.
  • Phase I trial of aclacinomycin A.
  • Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
  • A phase I clinical trial of aclacinomycin A administered on a five-consecutive-day schedule.
  • research_abst
  • Effects of heavy ions on rabbit tissues: cataractogenesis.
  • Effect of dietary selenium source, level, and pig hair color on various selenium indices.
  • research_abst
  • Fiber implantation for pattern baldness. Review of complications in forty-one patients.
  • Anticancer drugs induce apoptosis in mouse hair follicles.
  • Phase I clinical trial of 9,10-anthracene dicarboxaldehyde (Bisantrene) administered in a five-day schedule.
  • Canine cutaneous lymphoma.
  • Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancer.
  • A phase I and clinical pharmacology study of intravenously administered carminomycin in cancer patients in the United States.
  • Phase II trial of VP16-213 in non-small cell lung cancer (NSCLC).
  • Zinc deficiency and behavior: a development perspective.
  • Mitoxantrone: a phase II study in the treatment of patients with advanced breast carcinoma and other solid tumours.
  • Mutation of the human hairless gene in atrichia universalis
  • Changing patterns in the clinical features and prognosis of systemic lupus erythematosus - a Japanese experience.
  • Atopy and associated diseases
  • The strip scalp graft.
  • The 1982 revised criteria for the classification of systemic lupus erythematosus.
  • Zinc deficiency dermatoses. Etiology, clinical aspects and treatment
  • Tinea capitis in Brooklyn.
  • The goitrogenic effect of 4,4'-oxydianiline in rats and mice.
  • Juvenile autoimmune polyendocrinopathy.
  • 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated depression of rat testicular heme synthesis and microsomal cytochrome P-450.
  • Intra-arterial infusion chemotherapy with adriamycin for the treatment of locally advanced breast cancer--studies of serum and tissue concentrations of adriamycin
  • Molecular basis for the rhino (hrrh-8J) phenotype: a nonsense mutation in the mouse hairless gene.
  • Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinoma.
  • Scalp reduction as an adjunct to hair transplantation. Review of relevant literature and presentation of an improved technique.
  • Fenofibrate: animal toxicology in relation to side-effects in man
  • Cardiomyopathy and other chronic toxic effects induced in rabbits by doxorubicin and possible prevention by coenzyme Q10.
  • Toxicity of Leucaena leucocephala for steers in the wet tropics.
  • Iodine metabolism. 2. Effect of iodine deficiency on reproduction and the development of progeny of goats and miniature pigs
  • Efficacy of Post-operative Adjuvant Therapy for Stage IIIa Berast Cancer: Futraful vs Futraful+Tamoxifen for ER-positive Patients and Futraful vs Futraful+Adriamycin for ER-negative Breast Cancer.
  • Predicting hair growth for hair transplantations.
  • Prognostic variables in mycosis fungoides.
  • Phase I study on bruceantin administered on a weekly schedule.
  • Scalp autografts and hair transfer to the face in the burned child.
  • Medical treatment of baldness.
  • Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
  • Reactions and side effects of ovulation inhibitors on the skin
  • A phase of I trial of 4'-epi-Adriamycin.
  • Repeated exposure to alpha-ethylacrolein vapour: subacute toxicity study in rats.
  • Growth and development in postnatally zinc-deprived mice.
  • Phase II study of 5-fluorouracil and adriamycin in transitional cell carcinoma of the urinary tract.
  • Clinical observations, cutaneous lesions, and hematologic alterations in chronic adriamycin intoxication in dogs with and without vitamin E and selenium supplementation.
  • Studies of the components of an oral contraceptive agent in albino rats. II. Progestogenic component and comparison of effects of the components and the combined agent.
  • Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin, and DTIC (CAD).
  • 5-Fluorouracil prodrug: role of anabolic and catabolic pathway modulation in therapy of colorectal cancer.
  • Cutaneous manifestations in rats with advanced vitamin A deficiency.
  • Clinical study of detorubicin. EORTC Clinical Screening Group.
  • Long-term therapy of hereditary angioedema with danazol.
  • The diagnosis and treatment of canine hypothyroidism.
  • Clinical phase I-II and pharmacokinetic study of high-dose thymidine given by continuous intravenous infusion.
  • Auto-immune juvenile polyendocrinopathy
  • Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure.
  • research_abst
  • Phase I stu